Based on this, we speculate that COVID-19 will cause the downregulation of ACE2 in the intestinal mucosal cells during the infection process, leading to the disorder of the RAS system and the decline of the anti-inflammatory ability of the intestinal mucosa (Figure 1). This evidence concerns the gene ACE2 and infection.